Why the study?
Most previous studies focused on baseline risk factors and did not consider temporal changes in risk factor status in primary prevention settings.
Does a temporal change in cardiovascular risk factor status alter the risk of future ASCVD events in a primary prevention cohort?
Does a temporal change in cardiovascular risk factor status alter the risk of future ASCVD events in a primary prevention cohort?
Temporal changes in cardiovascular risk factor status significantly impact future ASCVD risk, highlighting the importance of continuous risk factor monitoring and management in primary prevention.
Answers are grounded in this paper and cite their sources.
Changes in risk factor status were associated with ASCVD events; hypothesis-generating for dynamic monitoring but leaves open causal impact on outcomes.
Primary cardiovascular prevention highlights the management of risk factors through lifestyle changes and therapeutic interventions. While most previous studies focused on the presence of risk factors assessed only at baseline, temporal changes in the risk factor status were not considered. We aimed to evaluate the prognostic impact of temporal changes in risk factor status in primary prevention settings. A population-based cohort of 211,077 individuals who underwent repetitive 10-year atherosclerotic cardiovascular disease (ASCVD) risk assessments over 4–5 years, was identified from National Health Insurance Services claims data of South Korea. Changes in risk-factor status for blood pressure, glycemic control, cholesterol levels, smoking status, body-mass index, and physical activity were assessed. Hazard ratios (HR) for ASCVD events after follow-up screening were calculated based on increased or decreased risk factors between baseline and follow-up. Regardless of baseline status, increased risk factors correlated with higher future ASCVD risk, while a decrease corresponded to a lower risk. Notably, individuals initially without risk factors but developing three at follow-up faced significantly higher ASCVD risk (adjusted HR 2.74, 95% CI: 1.31– 5.76). Conversely, those decreasing three risk factors from 5 or 6 exhibited almost a 50% reduction in ASCVD risk. These findings show that primary prevention effects can be reflected by changes in risk factor status, underscoring the need to monitor temporal changes in risk factors for effective primary prevention.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: